Harte-Hanks, Inc. (HHS) Reports In-Line Q2 EPS, Revenue Beat Expectations
Tweet
Share
E-mailGet Alerts HHS Hot Sheet
Price: $3.53 -2.22%
Financial Fact:
Operating income: -4.57M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Operating income: -4.57M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Harte-Hanks, Inc. (NYSE: HHS) reported Q2 adjusted EPS of $0.18, in-line with the analyst estimate of $0.18. Revenue for the quarter came in at $213 million versus the consensus estimate of $208.98 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
- ZKH Group Limited (ZKH) Reports Q2 EPS of $0.04
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
